C&K Cutting Edge Blog #1
By Roger Bohannan – C&K Medical Segment Leader
Diabetes is the fastest growing disease among the top 10 most lethal conditions in the human population. The diabetes patient population has grown to 420 million people over the past 15 years, according to the World Health Organization, and is slated to be 10% of the world’s population by 2045.
As the industry transforms tracking and measuring drug delivery, we move closer to solving some of our most vexing disease challenges – including but not exclusive to diabetes management. Physicians and scientists have confidence in scientific data during clinical studies. But confidence levels in tracking and measuring insulin dosing and delivery diminish as control migrates to the consumer health population. Connected devices are providing solutions.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.